Radiofrequency ablation and laparoscopic splenectomy for the treatment of small hepatocellular carcinoma with hypersplenism
10.3969/j.issn.1007-3969.2016.02.010
- VernacularTitle:小肝癌合并脾功能亢进的微创治疗的方法探讨
- Author:
Xintao ZENG
;
Hua LUO
;
Wei ZHANG
;
Xi CHEN
;
Daoning GUO
;
Pei YANG
- Publication Type:Journal Article
- Keywords:
Small hepatocellular carcinoma;
Contrast-enhanced ultrasound;
Laparoscopic splenectomy;
Radiofrequency ablation
- From:
China Oncology
2016;26(2):177-181
- CountryChina
- Language:Chinese
-
Abstract:
Background and purpose:Liver cancer resection and splenectomy are the main methods to treat hepatocellular carcinoma and hypersplenism. The aim of this study was to discuss the safety and feasibility of simultaneous radiofrequency ablation (RFA) and laparoscopic splenectomy (LS) for the treatment of small hepatocellular carcinoma with hypersplenism.Methods:Twenty-seven patients with small hepatocellular carcinoma and cirrhotic hypersplenism underwent RFA and LS. The clinical data were also analyzed.Results:The surgery was converted to an open surgery in 1 patient, while laparoscopic splenectomy in a hand-assisted manner was performed in 2 patients. There were 31 liver tumors treated with RFA. Blood loss were 110-900 mL (mean=320 mL). Operation time were 72-127 min (mean=107 min). Subcutaneous emphysema occurred in 1 patient, and pancreatic leakage in another patient. Nine patients developed ascites. one patient suffered from massive haemorrhage, and emergency operation was adopted to stop bleeding. This patient recovered well after operation. No death was found during the hospitalization. Conclusion:Combining RFA with LS for the treatment of liver cancer and hypersplenism is minimally invasive, safe, and feasible.
